Japanese encephalitis is a disease associated with a high mortality rate, and survivors often experience various degrees of neurological complications. Over the past few years, it has emerged as a significant public health concern. Approximately three billion people reside in countries where the Japanese encephalitis (JE) virus is endemic. Conservatively estimated, there are 50,000 to 175,000 reported cases annually, resulting in 10,000 to 15,000 deaths.
According to data from the Directorate of National Vector-Borne Disease Control Programme (NVBDCP) website, from January 1 to August 13 this year, 1208 cases of Acute Encephalitis Syndrome (AES) have been reported in Uttar Pradesh, with 152 of these cases leading to the death of the patient.
States such as Andhra Pradesh, West Bengal, Assam, Tamil Nadu, Karnataka, Bihar, Maharashtra, Manipur, Haryana, Kerala, and Uttar Pradesh are reporting the highest number of Japanese encephalitis cases.
Strategies for the prevention and control of Japanese encephalitis include:
Strengthening surveillance activities through sentinel sites in tertiary health care institutions.
Timely diagnosis and appropriate case management are crucial:
Integrated vector control includes:
Behavioral changes: Emphasis should be placed on keeping pigs away from human dwellings, particularly in pigsties, especially during the dusk-to-dawn period when vector mosquitoes are most active. Wearing clothes that fully cover the body to prevent mosquito bites is recommended. The use of bed-nets is also a crucial precaution. Implementing a complete ban on open defecation is essential. Piggeries should be kept away (4-5 km) from human dwellings.
Vaccines
Three types of vaccine are available
The program encompasses 60 districts with a high burden of Japanese Encephalitis (JE) and Acute Encephalitis Syndrome, spanning five states.
Multipronged Approach- Intersectoral collaboration to address the complex issue
The objective of the program is to decrease the incidence of Japanese Encephalitis (JE) and Acute Encephalitis Syndrome (AES) in children, leading to lower rates of morbidity, mortality, and disability.
The major objectives of the programme are as follows:
(i) Enhancing and broadening Japanese Encephalitis (JE) vaccination in affected districts.
(ii) Reinforcing surveillance, vector control, case management, and ensuring the timely referral of severe and complicated cases.
(iii) Increasing accessibility to safe drinking water and proper sanitation facilities for the target population in affected rural and urban areas.
(iv) Assessing the disability burden resulting from JE/AES and providing adequate facilities for physical, medical, neurological, and social rehabilitation.
(v) Improving the nutritional status of children at risk of JE/AES.
(vi) Conducting intensified Information, Education, and Communication/Behavior Change Communication (IEC/BCC) activities related to JE/AES.
7 videos|219 docs
|
1. What is Japanese Encephalitis? |
2. What are the symptoms of Japanese Encephalitis? |
3. How is Japanese Encephalitis transmitted? |
4. Is there a vaccine available for Japanese Encephalitis? |
5. How can Japanese Encephalitis be prevented? |
|
Explore Courses for UPSC exam
|